1-8 of 8
Stein Kvaløy
Close
Sort by
Journal Articles

Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (<61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab – 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group

Michael Pfreundschuh, MD, Evelyn Kuhnt, Lorenz Trümper, MD, Anders Osterborg, MD, PhD, Marek Trneny, MD, Lois Shepherd, MD, Devinder S Gill, MD, Jan Walewski, MD, Ruth Pettengell, FRACP, PhD, Ulrich Jäger, MD, Pier Luigi Zinzani, MD, PhD, Ofer Shpilberg, MD, MPH, Stein Kvaloy, MD, Mads Hansen, MD, Rolf Stahel, MD, Noel Milpied, MD, Armando Lopez-Guillermo, MD, Sandra Grass, MD, Niels Murawski, MD, Viola Pöschel, Markus Löffler
Journal: Blood
Blood (2010) 116 (21): 111.
https://doi.org/10.1182/blood.V116.21.111.111
Published: 2010
Journal Articles

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Georg Lenz, George Wright, Ph.D., Sandeep Dave, Wenming Xiao, John Powell, Hong Zhao, Weihong Xu, Bruce Tan, Neta Goldschmidt, Javeed Iqbal, Ph.D., Julie Vose, Martin A Bast, Kai Fu, Dennis D. Weisenburger, Timothy C. Greiner, James O. Armitage, Alastair Kyle, Lorraine May, Randy D. Gascoyne, Joseph M. Connors, Gunhild Troen, Harald Holte, Stein Kvaloy, Daan Dierickx, Gregor Verhoef, Jan Delabie, Erlend B. Smeland, Pedro Jares, Antonio Martinez, Armando Lopez-Guillermo, Emili Montserrat, Elias Campo, Rita M. Braziel, Thomas P. Miller, Lisa M. Rimsza, James R. Cook, Brad Pohlman, MD, John William Sweetenham, Raymond R. Tubbs, Richard I. Fisher, Elena Hartmann, Andreas Rosenwald, German Ott, Hans- Konrad Muller-Hermelink, David Wrench, T. Andrew Lister, Elaine S. Jaffe, Wyndham Wilson, Wing C. Chan, Louis M. Staudt, MD.
Journal: Blood
Blood (2008) 112 (11): 475.
https://doi.org/10.1182/blood.V112.11.475.475
Published: 2008
Journal Articles

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Georg Lenz, MD, George Wright, PhD, Sandeep Dave, MD, Alexander Kohlmann, PhD, Wenming Xiao, PhD, John Powell, MS, Hong Zhao, Weihong Xu, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Lorraine May, MD, Dennis D. Weisenburger, MD, Tim Greiner, MD, Julie Vose, MD, James O. Armitage, MD, Javeed Iqbal, MD, Martin Bast, MD, Kai Fu, MD, Elias Campo, MD, Emili Montserrat, MD, Armando Lopez-Guillermo, MD, Pedro Jares, MD, Antonio Martinez, MD, Betty Gibbs, MD, Lisa M. Rimsza, MD, Richard I. Fisher, MD, Rita M. Braziel, MD, Ray Tubbs, MD, James Cook, MD, Brad Pohlman, MD, John Sweetenham, MD, Gunhild Troen, MD, Erlend B. Smeland, MD, Jan Delabie, MD, Stein Kvaloy, MD, Harald Holte, MD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, Nicole Grant, MD, Elena Hartmann, MD, Andreas Rosenwald, MD, German Ott, MD, Hans-Konrad Muller-Hermelink, MD, T. Andrew Lister, MD, Mickey Williams, PhD, Lothar Wieczorek, PhD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 348.
https://doi.org/10.1182/blood.V110.11.348.348
Published: 2007
Journal Articles

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Adrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, George Wright, Federica Gibellini, Kazutaka Nakayama, Hui Liu, Andreas Rosenwald, H. Konrad Muller-Hermelink, German Ott, Wing C. Chan, Timothy C. Greiner, Dennis D. Weisenburger, Julie Vose, James O. Armitage, Randy D. Gascoyne, Joseph M. Connors, Elias Campo, Emilio Montserrat, Francesc Bosch, Erlend B. Smeland, Stein Kvaloy, Harald Holte, Jan Delabie, Richard I. Fisher, Thomas M. Grogan, Thomas P. Miller, Wyndham H. Wilson, Elaine S. Jaffe, Louis M. Staudt
Journal: Blood
Blood (2007) 109 (11): 4599–4606.
https://doi.org/10.1182/blood-2006-08-039859
Published: 2007
Journal Articles

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Clinical Trials & Observations
Silvia Bea, Andreas Zettl, George Wright, Itziar Salaverria, Philipp Jehn, Victor Moreno, Christof Burek, German Ott, Xavier Puig, Liming Yang, Armando Lopez-Guillermo, Wing C. Chan, Timothy C. Greiner, Dennis D. Weisenburger, James O. Armitage, Randy D. Gascoyne, Joseph M. Connors, Thomas M. Grogan, Rita Braziel, Richard I. Fisher, Erlend B. Smeland, Stein Kvaloy, Harald Holte, Jan Delabie, Richard Simon, John Powell, Wyndham H. Wilson, Elaine S. Jaffe, Emili Montserrat, Hans-Konrad Muller-Hermelink, Louis M. Staudt, Elias Campo, Andreas Rosenwald, for the Lymphoma/Leukemia Molecular Profiling Project
Journal: Blood
Blood (2005) 106 (9): 3183–3190.
https://doi.org/10.1182/blood-2005-04-1399
Published: 2005
Includes: Supplemental data
Journal Articles

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Andreas Zettl, MD, Silvia Bea, George Wright, PhD, Itziar Salaverria, Philipp Jehn, German Ott, MD, Wing-Chung Chan, MD, Elaine Jaffe, MD, Dennis Weisenburger, MD, Timothy Greiner, MD, James Armitage, MD, Randy Gascoyne, MD, Joseph Connors, MD, Thomas Grogan, MD, Thomas Miller, MD, Richard Fisher, MD, Jan Delabie, MD, Stein Kvaloy, MD, Hans Konrad Mueller-Hermelink, MD, Christof Burek, Victor Moreno, Emilio Montserrat, MD, Wyndham Wilson, MD, Louis Staudt, MD, PhD, Andreas Rosenwald, MD, Elias Campo, for the Leukemia Lymphoma Molecular Profiling Project
Journal: Blood
Blood (2004) 104 (11): 415.
https://doi.org/10.1182/blood.V104.11.415.415
Published: 2004
Journal Articles

High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA.

Adrian Wiestner, Michael Chiorazzi, Raymond Lai, Andreas Rosenwald, H. Konrad Muller-Hermelink, German Ott, Wing C. Chan, Timothy C. Greiner, Dennis D. Weisenburger, Julie Vose, James O. Armitage, Randy D. Gascoyne, Joseph M. Connors, Elias Campo, Emilio Montserrat, Francesc Bosch, Erlend B. Smeland, Stein Kvaloy, Harald Holte, Jan Delabie, Richard I. Fisher, Thomas M. Grogan, Thomas P. Miller, Wyndham H. Wilson, Elaine S. Jaffe, Louis M. Staudt
Journal: Blood
Blood (2004) 104 (11): 697.
https://doi.org/10.1182/blood.V104.11.697.697
Published: 2004
Journal Articles

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

Clinical Trials & Observations
Eva Ösby, Hans Hagberg, Stein Kvaløy, Lasse Teerenhovi, Harald Anderson, Eva Cavallin-Ståhl, Harald Holte, John Myhre, Hannu Pertovaara, Magnus Björkholm
Journal: Blood
Blood (2003) 101 (10): 3840–3848.
https://doi.org/10.1182/blood-2002-10-3238
Published: 2003